#profitability
Latest news and interesting information about profitability.
ISS Stock Jumps on Raised Outlook and Buyback Boost
ISS stock jumped nearly 7% after raising 2026 outlook and buyback program. Higher growth and margin targets set.
Wolfe Research Initiates Oklo with Peerperform
Wolfe Research initiated Oklo Inc. with a Peerperform rating. Learn about the company's targets, finances, and stock performance.
Aletheia Capital Reaffirms Circle Stock Rating
Aletheia Capital reaffirms Buy rating on Circle Internet Group amid U.S. stablecoin regulatory advantages. Stock at $111.39.
Magna International stock faces margin test amid guidance raise
Magna International stock is in focus with potential margin expansion and improved profitability. More insights from Bond.az.
10X Genomics SWOT: Profitability Test Ahead
10X Genomics SWOT analysis: profitability test, financial challenges, and market recovery potential. Single-cell and spatial analysis investment outlook.
Bakkafrost swings to profit, lifts Faroes harvest outlook
Bakkafrost swings to Q1 profit, raises Faroes harvest outlook. Bond.az brings you the latest corporate earnings updates.
Klaviyo SWOT Analysis: AI Growth and Margin Pressures
Klaviyo SWOT analysis: AI growth, margin pressures, and future outlook. Is the stock a buy?
StanChart to Cut Over 7,000 Jobs by 2030
StanChart announces job cuts of over 7,000 by 2030, raises profitability target.
Dover Corporation SWOT: Margin Pressures Weigh
Dover Corporation SWOT analysis: margin pressures, organic growth, M&A potential, and risks for investors. Detailed insights on Bond.az.
Mirum Director Sells $218,940 in Stock
Mirum Pharmaceuticals director Saira Ramasastry sells $218,940 in stock. Read about the transaction and company outlook.
Telix completes enrollment in glioblastoma therapy trial
Telix Pharmaceuticals completes patient enrollment for TLX101-Tx glioblastoma therapy trial.
FIBK's optimization test amid pressures
FIBK (First Interstate BancSystem) balance sheet optimization, earnings estimates, and strategic focus. Analysis of risks and opportunities.
StanChart CEO faces strategy test amid growth push
Standard Chartered CEO Bill Winters faces a key test on Tuesday to convince investors the bank can deliver stronger growth after a long turnaround, amid geopolitical uncertainty.
Kaltura chief customer officer sells $9,540 in stock
Kaltura Chief Customer Officer Natan Israeli sold $9,540 worth of common stock. Shares were sold between $1.50 and $1.52. Market cap is $224.8 million.
Analysts: Long-term AI demand, but upside limited for Nebius, CoreWeave
D.A. Davidson analysts give Neutral ratings to Nebius and CoreWeave, citing long-term AI demand but limited near-term upside due to valuations and operational risks.
Natura & Co Q1 2026 EPS Beat, Stock Falls Despite Earnings
Natura & Co Q1 2026 results: EPS beat at $0.136, but revenue missed at $4.75B. Stock fell 7.3%. Company reaffirms margin and cash flow targets despite challenges.
Duos Tech Q1 2026 Misses Forecasts, Stock Volatile
Duos Technologies Group missed Q1 2026 EPS and revenue forecasts. The company is transitioning to data centers and secured a $176 million GPU-as-a-Service contract.
Minesto Q1 2025: Cash Flow Improves, Stock Drops 4%
Minesto Q1 2025 earnings show improved cash flow but stock drops 4.08%. CEO Edlund highlights cost discipline and tech progress. Read the full transcript on Bond.az.
Hims & Hers plans $300M convertible notes offering
Hims & Hers announces $300 million convertible notes offering due 2032 to fund international expansion and AI investments.
BioCryst stock: growth path ahead
BioCryst Pharmaceuticals stock analysis: Orladeyo growth, pediatric approval, profitability targets, and pipeline progress.
iHeartMedia Q1 2026: Mixed Results with EPS Miss
iHeartMedia Q1 2026 earnings: EPS miss but revenue beat. Digital audio and podcasting drive growth. Stock falls 14.6%.
Estadio Deportes launches programmatic ads
Estadio Deportes launches programmatic advertising service. Gana Media Group's Mexican sports platform automates ad buying with real-time bidding.
AI Boom Drives Record Memory-Chip Profits
AI boom drives record memory-chip profits, but cyclical risks loom. Read more on Bond.az.
Conifex Timber Q1 2026: Loss and Challenges
Conifex Timber reported Q1 2026 net loss of CAD 9.4 million. The company targets two-shift operations to restore profitability.
TOMI Q1 2026: Revenue growth and 13% stock surge
TOMI Environmental Solutions Q1 2026 revenue rose 5% to $1.65M, stock surged 13%. EPS missed but investor confidence remained high.
ARS Pharma Misses Q1 2026 EPS Forecast, Stock Drops
ARS Pharma Q1 2026 EPS miss leads to 8.56% stock drop. Neffy prescriptions triple but high costs pressure profits.
Global chip stocks fall: KOSPI selloff, US-Iran talks stall
Global chip stocks fell due to a KOSPI selloff and stalled US-Iran talks. Samsung, Nvidia, and other semiconductor firms declined.
Sumitomo Pharma Q4 2025 Beats EPS Forecasts
Sumitomo Pharma Q4 2025 earnings beat EPS forecasts. The company achieved record profitability in FY 2025, driven by strong U.S. sales of ORGOVYX and GEMTESA.
DA Davidson Initiates Unity Bancorp with Buy Rating
DA Davidson initiates Unity Bancorp with buy rating and $68 target. Strong growth outlook and dividend history highlighted.
BTIG Reiterates Neutral on Insight Molecular Amid FDA Review
BTIG reiterates Neutral rating on Insight Molecular Diagnostics (IMDX) as FDA reviews GraftAssureDx transplant test. Stock up 28% in a week. Revenue surges 116%.
...